Male birth control pill moves closer to reality
NCT ID NCT01382069
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new male hormone pill, dimethandrolone undecanoate (DMAU), as a potential daily contraceptive for men. Researchers gave single and repeated doses to 100 healthy men aged 18-50 to check safety and how the drug works in the body. The goal is to develop a reliable, hormone-based birth control option for men.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY MEN are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Los Angeles Biomedical Research Institute
Torrance, California, 90502, United States
-
University of Washington
Seattle, Washington, 98195, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Male birth control pill enters human testing
- Hormone gel transfer: does washing or clothing protect women?
- New male birth control pill could work in minutes
- Hydrogel implant could offer reversible male contraception
- New male pill aims to stop sperm production
- Male birth control pill moves closer to reality